标题
Normal and malignant megakaryopoiesis
作者
关键词
-
出版物
EXPERT REVIEWS IN MOLECULAR MEDICINE
Volume 13, Issue -, Pages -
出版商
Cambridge University Press (CUP)
发表日期
2011-10-21
DOI
10.1017/s1462399411002043
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis
- (2011) P. Guglielmelli et al. BLOOD
- SCL-mediated regulation of the cell-cycle regulator p21 is critical for murine megakaryopoiesis
- (2011) H. Chagraoui et al. BLOOD
- Transcription factor networks in erythroid cell and megakaryocyte development
- (2011) L. C. Dore et al. BLOOD
- TAp73α binds the kinetochore proteins Bub1 and Bub3 resulting in polyploidy
- (2011) Patrizia Vernole et al. CELL CYCLE
- Myeloproliferative Neoplasms: Molecular Pathophysiology, Essential Clinical Understanding, and Treatment Strategies
- (2011) Ayalew Tefferi et al. JOURNAL OF CLINICAL ONCOLOGY
- Clonal hierarchy and allelic mutation segregation in a myelofibrosis patient with two distinct LNK mutations
- (2011) T L Lasho et al. LEUKEMIA
- Aurora B is dispensable for megakaryocyte polyploidization, but contributes to the endomitotic process
- (2010) L. Lordier et al. BLOOD
- Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms
- (2010) S. T. Oh et al. BLOOD
- Serum response factor is an essential transcription factor in megakaryocytic maturation
- (2010) S. Halene et al. BLOOD
- Myeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice
- (2010) C. Marty et al. BLOOD
- FOG1 requires NuRD to promote hematopoiesis and maintain lineage fidelity within the megakaryocytic-erythroid compartment
- (2010) G. D. Gregory et al. BLOOD
- Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease
- (2010) H. Akada et al. BLOOD
- JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia
- (2010) J. Li et al. BLOOD
- Distinct Clinical Phenotypes Associated with JAK2V617F Reflect Differential STAT1 Signaling
- (2010) Edwin Chen et al. CANCER CELL
- Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor Cells
- (2010) Ann Mullally et al. CANCER CELL
- Therapeutic Potential of Janus-activated Kinase-2 Inhibitors for the Management of Myelofibrosis
- (2010) S. Verstovsek CLINICAL CANCER RESEARCH
- Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis
- (2010) J.-H. Klusmann et al. GENES & DEVELOPMENT
- New Roles for Cyclin E in Megakaryocytic Polyploidization
- (2010) Alexia Eliades et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humans
- (2010) Sachie Marubayashi et al. JOURNAL OF CLINICAL INVESTIGATION
- Lnk constrains myeloproliferative diseases in mice
- (2010) Alexey Bersenev et al. JOURNAL OF CLINICAL INVESTIGATION
- Critical Role of Pcid2 in B Cell Survival through the Regulation of MAD2 Expression
- (2010) T. Nakaya et al. JOURNAL OF IMMUNOLOGY
- JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations
- (2010) A Pardanani et al. LEUKEMIA
- The serum response factor (SRF)/megakaryocytic acute leukemia (MAL) network participates in megakaryocyte development
- (2010) C Ragu et al. LEUKEMIA
- IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis
- (2010) A Tefferi et al. LEUKEMIA
- LNK mutation studies in blast-phase myeloproliferative neoplasms and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations
- (2010) A Pardanani et al. LEUKEMIA
- Deletions of the transcription factor Ikaros in myeloproliferative neoplasms
- (2010) R Jäger et al. LEUKEMIA
- LIF-independent JAK signalling to chromatin in embryonic stem cells uncovered from an adult stem cell disease
- (2010) Dean S. Griffiths et al. NATURE CELL BIOLOGY
- Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
- (2010) Thomas Ernst et al. NATURE GENETICS
- Somatic Mutations ofIDH1andIDH2in the Leukemic Transformation of Myeloproliferative Neoplasms
- (2010) Anthony Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- LNKMutations inJAK2Mutation–Negative Erythrocytosis
- (2010) Terra L. Lasho et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome
- (2009) S. Malinge et al. BLOOD
- ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells
- (2009) M. J. Stankiewicz et al. BLOOD
- Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis
- (2009) C. Gekas et al. BLOOD
- Survivin is not required for the endomitotic cell cycle of megakaryocytes
- (2009) Q. Wen et al. BLOOD
- Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells
- (2009) Y. Wang et al. BLOOD
- Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms
- (2009) F. H. Grand et al. BLOOD
- ERG Is a Megakaryocytic Oncogene
- (2009) S. Salek-Ardakani et al. CANCER RESEARCH
- NuRD mediates activating and repressive functions of GATA-1 and FOG-1 during blood development
- (2009) Annarita Miccio et al. EMBO JOURNAL
- JAK3: A two-faced player in hematological disorders
- (2009) Melanie G. Cornejo et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Mutations of ASXL1 gene in myeloproliferative neoplasms
- (2009) N Carbuccia et al. LEUKEMIA
- JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin
- (2009) Mark A. Dawson et al. NATURE
- Mutation inTET2in Myeloid Cancers
- (2009) François Delhommeau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia
- (2009) I. Radtke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- P19INK4D links endomitotic arrest and megakaryocyte maturation and is regulated by AML-1
- (2008) L. Gilles et al. BLOOD
- Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia
- (2008) A. M. Vannucchi et al. BLOOD
- MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort
- (2008) P. A. Beer et al. BLOOD
- Primitive erythropoiesis and megakaryopoiesis in the yolk sac are independent of c-myb
- (2008) J. Tober et al. BLOOD
- Megakaryocyte endomitosis is a failure of late cytokinesis related to defects in the contractile ring and Rho/Rock signaling
- (2008) L. Lordier et al. BLOOD
- SCL and associated proteins distinguish active from repressive GATA transcription factor complexes
- (2008) T. Tripic et al. BLOOD
- Functional analysis of JAK3 mutations in transient myeloproliferative disorder and acute megakaryoblastic leukaemia accompanying Down syndrome
- (2008) Tomohiko Sato et al. BRITISH JOURNAL OF HAEMATOLOGY
- New mutations of MPL in primitive myelofibrosis: only the MPL W515 mutations promote a G1/S-phase transition
- (2008) R Chaligné et al. LEUKEMIA
- OTT-MAL Is a Deregulated Activator of Serum Response Factor-Dependent Gene Expression
- (2008) A. Descot et al. MOLECULAR AND CELLULAR BIOLOGY
- Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice
- (2007) R. Tiedt et al. BLOOD
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now